
TY  - JOUR
TI  - THE 23rd ANNUAL MEETING OF NORDISK NEUROKIRURGISK FÖRENING
JO  - Acta Neurologica Scandinavica
VL  - 48
IS  - 2
SN  - 0001-6314
UR  - https://doi.org/10.1111/j.1600-0404.1972.tb07546.x
DO  - doi:10.1111/j.1600-0404.1972.tb07546.x
SP  - 249
EP  - 264
PY  - 1972
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 9
IS  - s1
SN  - 1365-182X
UR  - https://doi.org/10.1080/16515320701258846
DO  - doi:10.1080/16515320701258846
SP  - 36
EP  - 110
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
VL  - 2
IS  - s3
SN  - 1600-6135
UR  - https://doi.org/10.1034/j.1600-0854.2004.000000141.x
DO  - doi:10.1034/j.1600-0854.2004.000000141.x
SP  - 417
EP  - 444
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
VL  - 5
IS  - s11
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6135.2005.abstracts.x
DO  - doi:10.1111/j.1600-6135.2005.abstracts.x
SP  - 155
EP  - 576
PY  - 2005
ER  - 

TY  - JOUR
AU  - Tan, Walter A.
AU  - Chough, Simon
AU  - Saito, Jerel
AU  - Wholey, Mark H.
AU  - Eles, Gustav
TI  - Covered stent for renal artery aneurysm
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 52
IS  - 1
SN  - 1522-1946
UR  - https://doi.org/10.1002/1522-726X(200101)52:1<106::AID-CCD1026>3.0.CO;2-Z
DO  - doi:10.1002/1522-726X(200101)52:1<106::AID-CCD1026>3.0.CO;2-Z
SP  - 106
EP  - 109
KW  - refractory hypertension
KW  - visceral
KW  - angioplasty
KW  - infarction
KW  - bifurcation
PY  - 2001
AB  - Abstract This is a case of a 51-year-old female with difficult-to-control hypertension and a 3-cm renal artery aneurysm. Successful exclusion of this was performed using a prefabricated stent graft. To our knowledge, this is the first report on the use of a prefabricated covered stent for this indication. Cathet Cardiovasc Intervent 2001;52:106?109. ? 2001 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
AU  - Armor, Jess F.
AU  - Fazili, Javid
AU  - Toubia, Nagib
AU  - Kern, William
AU  - Kamble, Rammurti
AU  - Kharfan-Dabaja, Mohamed A.
TI  - Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 78
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.20286
DO  - doi:10.1002/ajh.20286
SP  - 212
EP  - 215
KW  - natural-killer lymphoma
KW  - hepatitis C
KW  - chronic natural-killer cell leukemia
PY  - 2005
AB  - Abstract Non-Hodgkin lymphomas (NHL) consist of a diverse group of lymphoproliferative neoplasms with unique patterns of biology, behavior, and differing responses to therapy. A rare subtype of malignancy arising from cells of putative natural killer (NK) origin is being recognized as a distinct clinicopathological entity. Viruses including hepatitis C have been reported in association with various types of NHL but not the NK-cell subtype. We hereby report a unique case of a patient with hepatitis C who developed hepatic NK-cell lymphoma and chronic NK-cell leukemia. Interestingly, we observed clinical and radiologic remission of the neoplasm following treatment with anti-hepatitis C therapy. Am. J. Hematol. 78:212?215, 2005. ? 2005 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

TY  - JOUR
AU  - Mar, Nataliya
AU  - Gorgan, Maria A.
AU  - Dailey, Mark E.
AU  - Vredenburgh, James J.
TI  - Blue toes and a new pair of shoes—Challenges in diagnosis and treatment of acute myelogenous leukemia
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 88
IS  - 12
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.23563
DO  - doi:10.1002/ajh.23563
SP  - 1090
EP  - 1093
PY  - 2013
ER  - 

TY  - JOUR
TI  - Surgical Research Society
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 61
IS  - 4
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.1800610417
DO  - doi:10.1002/bjs.1800610417
SP  - 318
EP  - 332
PY  - 1974
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 14
IS  - s7
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2008.02007.x
DO  - doi:10.1111/j.1469-0691.2008.02007.x
SP  - S121
EP  - S666
PY  - 2008
ER  - 

AU  - Dey, Abhijit
C7  - pp. 185-246
TI  - Natural Products against Huntington's Disease (HD): Implications of Neurotoxic Animal Models and Transgenics in Preclinical Studies
SN  - 9783527341863
UR  - https://doi.org/10.1002/9783527803781.ch8
DO  - doi:10.1002/9783527803781.ch8
SP  - 185-246
KW  - Huntington's disease
KW  - natural products
KW  - neurotoxic
KW  - transgenic
KW  - synergism
PY  - 2008
AB  - Summary Huntington's disease (HD) is a neurological disorder characterized by abnormal body movements (chorea) associated with cognitive and motor dysfunctions, neuropsychiatric disturbances, and striatal damage. 3-Nitropropionic acid (3-NP) triggers cellular energy deficit, nitric oxide (NO) mechanisms, and oxidative stress (OS)-induced neurotoxicity by inhibiting the activity of mitochondrial complex II enzyme and succinate dehydrogenase in irreversible fashion. Chronic systemic administration of 3-NP to animals produces preferential degeneration of the striatum, leading to motor and cognitive deficits, closely resembling HD. Besides 3-NP model of striatal neurodegeneration, a number of transgenic animal models expressing mutant proteins are routinely used in preclinical trials exploring anti-HD therapeutics. In this review, the roles of a number of plant extracts, fractions, and isolated compounds investigated in various neurotoxic animal models and transgenics are discussed, highlighting on their ability to influence signaling pathways, leading to neuromodulation and probable neuroprotection. Since mitochondrial involvement and OS are also common phenomena in etiopathogenesis of a number of neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD), a few plant-based anti-HD natural products have been found efficacious against such diseases. Therapeutic advancement in screening of natural products against HD suffers from constraints such as limited animal models and giving maximum emphasis on cellular models during experimentations. However, recent progress in animal HD transgenic models expressing mutant proteins may reveal the therapeutic efficacy of natural products against HD, a disease with less elucidated pathogenesis and inadequate treatment strategies.
ER  - 

TY  - JOUR
TI  - Foot & mouth disease
JO  - Clinical Microbiology and Infection
VL  - 8
IS  - s1
SN  - 9783527341863
UR  - https://doi.org/10.1111/j.1469-0691.2002.tb00013.x
DO  - doi:10.1111/j.1469-0691.2002.tb00013.x
SP  - 1
EP  - 394
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S2
SN  - 9783527341863
UR  - https://doi.org/10.1111/ajt.14155
DO  - doi:10.1111/ajt.14155
SP  - 11
EP  - 92
PY  - 2017
ER  - 

TY  - JOUR
TI  - WHS Annual Meeting Abstracts
JO  - Wound Repair and Regeneration
VL  - 9
IS  - 2
SN  - 9783527341863
UR  - https://doi.org/10.1046/j.1524-475x.2001.00138.x
DO  - doi:10.1046/j.1524-475x.2001.00138.x
SP  - 138
EP  - 173
PY  - 2001
ER  - 

TY  - JOUR
TI  - Poster Session III (Abstracts 1195 – 1637)
JO  - Hepatology
JA  - Hepatology
VL  - 64
IS  - S1
SN  - 9783527341863
UR  - https://doi.org/10.1002/hep.28799
DO  - doi:10.1002/hep.28799
SP  - 601
EP  - 810
PY  - 2016
ER  - 

TY  - JOUR
TI  - Live Posters
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 34
IS  - S1
SN  - 9783527341863
UR  - https://doi.org/10.1111/pde.13195
DO  - doi:10.1111/pde.13195
SP  - S28
EP  - S99
PY  - 2017
ER  - 

TY  - JOUR
TI  - 2017 Annual Meeting of the American Society for Bone and Mineral Research, Colorado Convention Center, Denver, CO, USA — September 8–11, 2017
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 32
IS  - S1
SN  - 9783527341863
UR  - https://doi.org/10.1002/jbmr.3363
DO  - doi:10.1002/jbmr.3363
SP  - S1
EP  - S432
PY  - 2017
ER  - 

TY  - JOUR
TI  - ACRT-SCTS Scholar Abstracts
JO  - Clinical and Translational Science
VL  - 3
IS  - 2
SN  - 9783527341863
UR  - https://doi.org/10.1111/j.1752-8062.2010.00181_2.x
DO  - doi:10.1111/j.1752-8062.2010.00181_2.x
SP  - S8
EP  - S55
PY  - 2010
ER  - 

TY  - JOUR
TI  - IP and Lung Cancer Sig Poster Presentation
JO  - Respirology
JA  - Respirology
VL  - 19
IS  - S2
SN  - 9783527341863
UR  - https://doi.org/10.1111/resp.12263_3
DO  - doi:10.1111/resp.12263_3
SP  - 65
EP  - 72
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Mycoses
JA  - Mycoses
VL  - 58
IS  - S4
SN  - 9783527341863
UR  - https://doi.org/10.1111/myc.12380
DO  - doi:10.1111/myc.12380
SP  - 51
EP  - 226
PY  - 2015
ER  - 
